Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAFindings from the first-in-human phase I study
Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.
ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH
© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Un nuevo paradigma del mieloma múltiple con más calidad de vida | 0 | 6.48 | 05-10-2026 |
| 2 | FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma | 0 | 15.43 | 07-10-2026 |
| 3 | Artrite reumatoide, con le CAR-T spegneremo la reazione anomala dell’organismo nelle forme gravissime | 0 | 10.96 | 14-09-2026 |
| 4 | 再発または難治性の多発性骨髄腫患者さんを対象の第3相試験でエテンタミグの良好なトップライン結果を発表 | 0 | 10 | 28-09-2026 |
| 5 | EMA Recommends Granting a Marketing Authorisation for Ensartinib | 0 | 13.61 | 09-10-2026 |
| 6 | Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma | 0 | 12.74 | 09-09-2026 |
| 7 | В Мурманске ребёнку с лейкозом впервые провели современную иммунотерапию | 0 | 7.07 | 09-10-2026 |
| 8 | Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma | 0 | 15.89 | 10-09-2026 |
| 9 | Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer | 0 | 6.4 | 01-09-2026 |